ABRYSVO
Generic: Respiratory Syncytial Virus Vaccine
- Manufacturer
- Pfizer
- NDC
- 0069-0344
- Route
- INTRAMUSCULAR
- ICD-10 indication
- J12.1, J20.5
Affordability Check
How much will you actually pay for ABRYSVO?
In 30 seconds, see every legitimate way to afford ABRYSVO — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Respiratory Syncytial Virus Vaccine.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup ABRYSVO →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Respiratory Syncytial Virus Vaccine →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Medicare Part D coverage
How ABRYSVO appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).
Covered by plans
76%
4,194 of 5,509 plans
Most common tier
Tier 1
On 54% of covering formularies
Prior authorization required
21%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 178 | 54% |
| Tier 2 (generic) | 11 | 3% |
| Tier 3 (preferred brand) | 100 | 30% |
| Tier 4 (non-preferred brand) | 4 | 1% |
| Tier 6 | 36 | 11% |
Step therapy: 0% of formularies
Quantity limits: 41% of formularies
Coverage breadth: 329 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Irinotecan Hydrochloride 100 mg/5 mL
Also from Pfizer
Viagra
Also from Pfizer · sildenafil citrate
Inluriyo
Also from Pfizer · imlunestrant
Carbocaine
Also from Pfizer · Mepivacaine Hydrochloride
Bupivacaine
Also from Pfizer · BUPIVACAINE HYDROCHLORIDE
Vitamin B Complex
Also from Pfizer · thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamide
Ellence
Also from Pfizer · epirubicin hydrochloride
Doxepin HCL
Also from Pfizer · Doxepin HCL
METHYLPREDNISOLONE ACETATE
Also from Pfizer · Methylprednisolone acetate
Cardioplegic
Also from Pfizer · Calcium Chloride, Magnesium Chloride, Potassium Chloride and Sodium Chloride
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.